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Background. To assess structural and functional status of the arteries in young and middle-aged men with recently developed CAD.
MethodsandResults.Atotalof78menaged28to50yearsunderwentcarotidultrasound,endothelialfunction,andarterialstiﬀness
measurements. Angiographically proven CAD was present in 49 patients. Carotid plaques were present in 45 (91.8%) patients with
CAD and in 8 (27.6%) men without CAD (P<0.001). Patients with CAD more often had multiple plaques (86.7% versus 13.8%,
P<0.001). The prevalence of carotid intima-media thickness (IMT) ≥0.9mm and of abnormal brachial artery ﬂow-mediated
dilatation (FMD) was not diﬀering in both groups. The mean aortic pulse wave velocity (PWV) was 6.8±1.3m/s for patients with
CAD and 5.8 ±0.9m/s for subjects without CAD (P<0.001). Aortic PWV above the 75th percentile of the “normal” samples was
found in 26 (53.1%) patients with CAD and in 7 (24.1%) subjects without CAD (P = 0.02). Aortic PWV was related to the severity
of CAD. Conclusions. Carotid plaques and increased aortic PWV may be more powerful predictors of the occurrence of CAD in
young and middle-aged men, than the presence of increased carotid IMT and abnormal brachial artery FMD.
1.Introduction
Current guidelines for the primary prevention of coronary
artery disease (CAD) recommend initial assessment and
risk stratiﬁcation with global risk assessment tools such
as the Framingham risk score (FRS), which is based on
traditional risk factors [1]. Recognizing that risk assessment
strategies may inadequately assess cardiovascular disease
(CVD) risk, noninvasive measures of atherosclerosis have
emerged as adjuncts to traditional cardiovascular disease
risk factors in an attempt to reﬁne risk stratiﬁcation
and the need for more aggressive preventive strategies
[2]. Arterial ultrasonography and tonometry are attractive
methods for detecting subclinical atherosclerosis because
they are noninvasive and relatively inexpensive. Testing for
alterations in arterial function and structure with these
methods includes measurement of carotid intima-media
thickness (IMT) and plaque, measurement of brachial artery
ﬂow-mediateddilatation(FMD),measurementofankle-arm
indexpressure(AAI),anddeterminationofaorticpulsewave
velocity (PWV) [3]. Prospective population-based studies
have shown that diagnosis of subclinical atherosclerosis in
asymptomatic patients may be considered as the screening
test for predicting subsequent CAD events [4].
The purpose of the present study was to assess structural
and functional status of the arteries in young and middle-
aged men with recently developed CAD, who have had
relatively low CVD risk before appearances of clinical
manifestations of the disease.
2.MaterialsandMethods
A total of 49 consecutive male patients if they were no more
than 50 years old who had been referred to our department
between January 2009 and December 2010 for assessment
of CAD was included in the present study. The inclusion
criteria were angiographically documented: (≥50% stenosis2 International Journal of Vascular Medicine
of one or more of the major epicardial coronary arteries)
CAD, recent (less than 6 months before the investigation)
appearance of the ﬁrst clinical features of CAD, and a stable
condition. The results of the assessment of structural and
functional status of the arteries were compared with those
of 29 practically healthy control male subjects matched for
age who were recruited from hospital staﬀ and their relatives.
All of them had normal ECG patterns, normal ﬁndings of
ultrasound examination of the heart, and negative treadmill
test results. Those with grade 2 and 3 arterial hypertension,
diabetes mellitus, or LDL cholesterol (LDL-C) >4.5mmol/L
were excluded from the study. All patients underwent a
measurement of carotid IMT and plaques, measurement of
brachial artery FMD, and ultrasonography determination of
aortic PWV.
2.1. Ultrasound Measurements. High-resolution B-mode
ultrasonography was performed with a 5–9MHz linear-
type probe (PHILIPS iU22 ultrasound system, Philips Inc).
Mean-IMT measurements were made in accordance with
a Consensus Statement from the American Society of
Echocardiography Carotid Intima-Media Thickness Task
Force [5]. The individual value of mean-IMT was the
mean of mean-IMTs of the right and left carotid arteries.
Maximum-IMT was deﬁned as the highest distance between
the far wall lumen-intima and media-adventitia ultrasound
interfaces taken bilaterally in the 1cm segment proximal
to the bifurcation. The individual value of maximum-IMT
was the maximum of mean-IMTs of the right and the left
carotidarteries.ThemeasurementofcarotidIMTandplaque
was made by the same skilled operator. The intraobserver
coeﬃcient of variation for repeated measures of carotid IMT
inourlaboratoryis5.3%.IMTconsideredbeingnormalifits
value was <0.9mm. The presence of atherosclerotic plaque
was estimated at 6 sites of carotid pool: the whole length
of both common carotid arteries (CCAs), both bifurcations,
and both internal carotid arteries (ICAs). Plaque was deﬁned
as a focal structure that encroached into the arterial lumen
demonstrated a thickness of ≥1.5mm as measured from the
media-adventitia interface to the intima-lumen interface [6].
Percent area stenosis was deﬁned in the region of maximum
plaque obstruction in the artery in the transverse view and
was obtained from measurements of the residual lumen area
and the original area.
Brachial FMD was assessed in a subject’s right arm in
the recumbent position after a 15min equilibration period
in a temperature-controlled room (22 to 25◦C). Brachial
artery diameter (BAD) was measured by B-mode ultrasound
images at end diastole. The artery was longitudinally imaged
∼5cm proximal to the antecubital crease, where the clearest
image was obtained and BAD was measured. After the
baseline resting scan, a pneumatic tourniquet placed at the
level of the mid forearm (proximal to the target artery)
was inﬂated until no blood ﬂow was detected through the
brachial artery with the Doppler probe, and this pressure
was held for 5min. Increased ﬂow was then induced
with sudden cuﬀ deﬂation, and a continuous scan was
performed for 1min. For the reactive hyperemia scan, BAD
measurementsweretaken45to60saftercuﬀdeﬂation.FMD
was calculated from the diameters as (reactive hyperemia
− baseline)/baseline × 100%. The measurement of brachial
artery FMD was made by the same skilled operator. The
intraobserver coeﬃcient of variation for repeated measures
of FMD in our laboratory is 9.2%. According to our previous
results of FMD measurement in 46 healthy individuals, the
values of FMD ranged from 4.1 to 22.2% (median, 8.1%),
and none of them had FMD < 4.0%, so we set the “severe
impaired” cutoﬀ value of FMD at <4.0%. The values of
FMD in the lower two tertiles (4–8%) were considered to be
“impaired”, and we considered FMD to be “normal” when
vasodilatory response of the brachial artery was >8%.
Aortic PWV was measured from serial Doppler ﬂow
signals obtained from the proximal (at the base of the
sternum) and distal (above the navel) aorta with Vivid 7 Car-
diovascular Ultrasound System (GE Healthcare). Digitized
data were recorded by custom programming for subsequent
analysis. A minimum of 10 beats was averaged for each
recording site using the QRS for synchronization. Three
separate runs were recorded for each participant, and all
usable runs were averaged. The distance between the jugular
notch and the navel sampling sites was measured above
the surface of the body with a metal tape measure. The
associated distance was divided by the diﬀerence in the time
from the QRS to the onset of the pulsed-wave Doppler
envelope in proximal and distal sites to produce aortic PWV.
The measurement of aortic PWV was made by the same
skilledoperator.Theintraobservercoeﬃcientofvariationfor
repeated measures of aortic PWV in our laboratory is 7.6%.
2.2. Statistical Analysis. Student’s t-test for continuous data
and χ2 test for categorical data were used to compare the
distribution of baseline characteristics between patients with
and without CAD. The diﬀerences between groups with
one-, two-, and three-vessel disease were analyzed using
Kruskal-Wallis analysis of variance (ANOVA) by ranks. The
association of CAD risk factors with premature CAD was
examined with logistic regression. P<0.05 was considered
statistically signiﬁcant.
3. Results
Clinical characteristics of the study patients are summarized
in Table 1. Patients with CAD when compared with subjects
without CAD more often had a family history (FamHx) of
premature CAD (P<0.01), low levels of HDL cholesterol
(HDL-C) (P = 0.04), and more often were smokers (P<
0.01). As for other characteristics, there was no signiﬁcant
diﬀerence between both groups. The OR with a FamHx of
premature CHD for the presence of CAD was 1.71 (95% Cl,
1.32 to 2.21), with smoking was 2.02 (95% Cl, 1.13 to 3.62),
and with low HDL-C was 1.52 (95% Cl, 1.04 to 2.12).
3.1. Carotid Ultrasound. Average carotid IMT was signiﬁ-
cantly higher in CAD (0.88 ± 0.23mm) relative to non-CAD
patients (0.76 ± 0.18mm, P = 0.01) (Table 2). Eighteen
(36.7%) out of 49 patients with CAD and ﬁve (17.2%) out ofInternational Journal of Vascular Medicine 3
Table 1: Clinical characteristic.
CAD (n = 49) No CAD (n = 29)
Age (years) 43 ± 54 3 ± 6
History of myocardial
infarction (%) 41 (80%) —
Body mass index (kg/m2) 26.8 ± 3.5 26.4 ± 3.7
Hypertension (%) 2 (4%) 5 (17%)
Total cholesterol (mmol/L) 5,1 ± 1,0 5,1 ± 0,7
LDL-cholesterol (mmol/L) 3,3 ± 0,9 3,3 ± 0,6
HDL-cholesterol (mmol/L) 1,0 ± 0,2 1,1 ± 0,2
HDL-cholesterol
<1.03mmol/L (%) 28 (57%)∗∗ 9 (31%)
Triglycerides (mmol/L) 1,8 ± 0,6 1,4 ± 0,8
Currently smokers (%) 42 (86%)∗ 15 (52%)
Family history of CAD 14 (29%)∗ 1( 3 % )
Angiographic characteristics
One-vessel disease (%) 17 (35%) —
Two-vessel disease (%) 17 (35%) —
Triple-vessel disease (%) 15 (30%) —
∗P<0.01; ∗∗P = 0,04 for diﬀerence compared with no CAD.
CAD: coronary artery disease.
29 patients in control group had carotid IMT ≥0.9mm, but
thisdiﬀerencewasstatisticallyinsigniﬁcant(P = 0.08).There
was no correlation between carotid IMT and the severity of
CAD as assessed by coronary angiography.
AmongpatientswithCAD,91.8%oftheparticipantshad
at least 1 carotid plaque, 86.7% had more than 1 plaque, and
one (2%) patient had signiﬁcant (60%) stenosis (Table 2).
Among patients without CAD, 27.6% of the participants
had carotid plaques which were notably lower than in CAD
patients (P<0.001), and none of the control subjects had
stenosis of 60% or more. Four (13.8%) out of 29 patients
had more than 1 plaque that was lower than in patients with
CAD (P<0.001) The severity of CAD did not signiﬁcantly
correlate with the presence of carotid plaques.
3.2. Endothelial Function. Mean systolic blood pressure
during measuring of FMD in patients with CAD (117 ±
7mmHg) and in patients of control group (115 ± 7mmHg)
did not diﬀer signiﬁcantly. Mean brachial artery FMD was
4.5 ± 2.8% in patients with CAD (Table 2). Regarding the
severity of disturbances, 46.9% of the participants had severe
abnormal (<4%) FMD, 42.9% had abnormal (4–8%) FMD,
and10.2%hadnoabnormalitiesofFMD.Inpatientswithout
CAD, mean brachial artery FMD was 5.8 ± 2.2% which was
lower than in patients with CAD (P = 0.03). 34.5% of the
participantshadsevereabnormalFMD,48.3%hadabnormal
FMD,and17.2%hadnoabnormalitiesofFMD.Frequencyof
abnormalFMDvaluesdidnotdiﬀerbetweenthetwogroups.
We did not ﬁnd association between the severity of CAD and
the presence of abnormal FMD.
3.3. Arterial Stiﬀness. Mean systolic blood pressure during
measuring of PWV in patients with CAD (120 ± 6mmHg)
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Figure 1: Aortic PWV in CAD patients. (1) one-vessel disease,
(2) two-vessel disease, (3) triple-vessel disease. P<0.01 (Kruskal-
Wallis ANOVA by Ranks).
and in patients of control group (118 ± 5mm Hg) did
not diﬀer signiﬁcantly. Mean aortic PWV was 5.8 ± 0.9m/s
(median, 5.6m/s; range, 4.4–7.8m/s) in control subjects
(Table 2). The upper quartile (above which PWV was
deemed “above normal”) was 6.5m/s. Mean aortic PWV was
6.8 ± 1.3m/s (median, 6.9m/s; range, 4.6–10.0m/s) in CAD
patients which was higher than in patients without CAD
(P<0.001). A higher proportion of patients with CAD had
PWV ≥6.5m/s(53.1%versus24.1%;P = 0.02).Meanaortic
PWV was 6.0 ± 1.1m/s, 6.7 ± 1.1m/s and 7.7 ± 1.2m/s in
patients with one-vessel, two-vessel, and three-vessel disease,
accordingly. These diﬀerences were statistically signiﬁcant
(Figure 1).
Adjusted for FamHx of premature CAD, smoking, and
low level of HDL-C, the existence of carotid plaques [5.3
(95% Cl, 2.14 to 13.12)] and increased aortic PWV [1.54
(95% Cl, 1.11 to 2.15)] were still related to the presence of
CAD.
4. Discussion
Most information concerning prognostic value of noninva-
sive measures of arterial function and structure have been
derived from the study of older populations. Therefore,
there is a need to identify younger subjects at risk for
CVD so that preventive measures may be instituted before
occlusive vascular disease occurs. Patients with premature
CAD included in this study were 26–50 years old, none
of them had diabetes mellitus, 55% had normal values of
LDL-C, and only 2 patients had mild arterial hypertension.
First clinical CAD event, which was myocardial infarction
in most (73%) patients, occurred without prior warning.
96% of patients may be considered at low and intermediate4 International Journal of Vascular Medicine
Table 2: Structural and functional status of the arteries in young and middle-aged men with recently developed CAD.
Variable CAD (n = 49) No CAD (n = 29) P
Carotid IMT (mm) 0.88 ± 0.23 0.76 ± 0.18 0.01
≥0.9mm (%) 18 (36.7%) 5 (17.2%) NS
Carotid plaques (%) 45 (91.8%) 8 (27.6%) <0.001
More than 1 plaque (%) 39 (86.7%) 4 (13.8%) <0.001
Brachial artery FMD (%) 4.5 ± 2.8 5.8 ± 2.2 0.03
>8% (%) 5 (10.2%) 5 (17.2%) NS
Aortic PWV 6.8 ± 1.3 5.8 ± 0,9 <0/001
≥6,5m/s 26 (53.1%) 7 (24.1%) 0.02
CAD, coronary artery disease; IMT, intima-media thickness; FMD, ﬂow-mediated dilatation; PWV, pulse wave velocity.
risk for future cardiovascular events when assessed with
Framingham Risk Score method the day before ﬁrst clinical
manifestations of CAD. Patients with CAD included in this
study when compared with subjects without CAD more
oftenhadaFamHxofprematureCAD.Itseemsthataddition
of FamHx of premature CAD to global CVD risk models
may improve prediction for future cardiovascular events in
young and middle-aged patients. Potential value of inclusion
FamHxofprematureCADtoglobalCVDriskassessmenthas
been demonstrated in several studies [7, 8].
Young and middle-aged men with a FamHx of prema-
ture CAD are candidates for quantiﬁcation of subclinical
atherosclerosis by noninvasive measures [9]. There is a
lot of diﬀerent noninvasive tests for diagnosis of sub-
clinical atherosclerosis. The implementation of subclinical
atherosclerosis testing in the risk management of patients
is dependent on a better knowledge of the comparative
prognostic performance of currently available tests. Among
themvascularultrasonographyandtonometryarepromising
test modalities for assessment of arterial function and struc-
ture in asymptomatic subjects because they are noninvasive
and relatively inexpensive. The prognostic value of each of
them has been shown in prospective studies [4, 10], but
the diﬀerent types of subclinical atherosclerosis tests have a
diﬀerent prognostic performance [11].
The present study demonstrates that young and middle-
aged men with premature CAD when compared with sub-
jects without CAD more often have atherosclerotic plaques
in the extracranial carotid arteries. Also patients with CAD
more often have more than 1 plaque. This is concordant
withpreviousstudies,whichhaveshownassociationbetween
the presences of carotid plaques and CAD incidence [4, 12,
13]. 13221 low-risk, healthy, asymptomatic individuals were
included in a 10-year prospective, followup-based CAFES-
CAVE study [13]. The aim of the study was to assess the
relation between subclinical arteriosclerotic lesions at the
carotidandfemoralarteriesidentiﬁedbyB-modeultrasound
and the occurrence of future CVD events. Four classes were
considered at inclusion (I: normal wall, II: wall thickening,
III:nonstenosingplaques,IV:stenosingplaques).In10years,
there were 0.1% events in class I, 8.6% events in class II,
39% events in class III, and 81% events in class IV. The
increased event rates in classes III and IV were signiﬁcant in
comparison with I and II.
Patients with CAD included in this study had greater
mean value of IMT. However, the diﬀerence between the
occurrences of increased (≥0.9mm) IMT values in both
groups was statistically insigniﬁcant. Analysis of prospective
epidemiological data in the general population was per-
formed by Simon et al. [14] to determine the association
of carotid IMT with CVD risk. They revealed that carotid
IMT is an independent but relatively modest (as judged by
absolute risk) predictor of CAD, carotid IMT adds little to
the CHD prediction by risk factors, and plaque may be more
representative of atherosclerosis than carotid IMT.
In our study, mean brachial artery FMD was lower in
patients with CAD when compared with subjects without
CAD, but the frequency of impaired FMD was the same
in both groups. The assessment of FMD as a noninvasive
approach to examine vasodilator function has been used to
compare groups of subjects and to evaluate the impact of
interventions within individuals. Data about the incremental
prognostic value of FMD in asymptomatic subjects are lim-
ited. Anderson et al. [10] prospectively examined 1574 men
(age, 49.4 years) free of vascular disease. These subjects had
low median FRS (7.9%), and FMD was not associated with
subsequent cardiovascular events (hazard ratio, 0.92; P =
0.54). Contrary to these ﬁndings, Yeboah et al. [15]f o u n d
that brachial FMD is a predictor of incident cardiovascular
events in population-based adults. Also the addition of
FMD to the FRS did not improve discrimination of subjects
at risk of CVD events in receiver operating characteristic
analysis; it improved the classiﬁcation of subjects as low,
intermediate, and high CVD risk compared with the FRS.
Despite FMD widespread adoption, there is considerable
variability between studies with respect to the protocols
applied, methods of analysis, and interpretation of results.
Moreover, diﬀerences in methodological approaches have
important impacts on the response magnitude, can result in
spurious data interpretation, and limit the comparability of
outcomes between studies [16].
According to our data, patients with CAD had higher
meanaorticPWV.Signiﬁcantlyhigherproportionofpatients
with CAD had PWV above “normal” (≥6.5m/s) value.
Moreover, there were association between the severity of
CAD and the value of aortic PWV. The patients with
CAD more often had therapy with ACE-inhibitors and
statins, which may positively aﬀect FMD and PWV. But inInternational Journal of Vascular Medicine 5
spite of this possible positive inﬂuence, patients with CAD
more often had increased aortic PWV. There is evidence
that increased aortic PWV is a predictor of subsequent
CVD events in a general population [17]. PWV is usually
measured by the foot-to-foot velocity method from various
waveforms [18]. There is a variety of diﬀerent waveforms
including pressure, distension, and Doppler. The method
we used in our study to calculate aortic PWV is based on
Doppler probes. Whether it has any advantage as compared
to more traditional methods based on pressure sensors
remains to be seen, and normal values will need to be
established for wider introduction of this method in clinical
practice.
5. Conclusions
In summary, the results of the present study demonstrate
that young and middle-aged men with recently developed
CAD more often have structural and functional status
abnormalitiesofthearteries,suchasmultiplecarotidplaques
and increased aortic PWV. These abnormalities may be
more powerful predictors of the occurrence of CAD in
young and middle-aged men, than the presence of increased
carotid IMT and abnormal brachial artery FMD. These
ﬁndings support the concept that assessment of structural
and functional status of the arteries may play a role as an
additional strategy to identify patients who would beneﬁt
from aggressive preventive measures.
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